Process chemistry plays a pivotal role in various stages of the pharmaceutical R&D cycle. However, support for preclinical and early clinical phases demands a delicate balancing act different from late clinical phases and commercialization. Early stage 'fit-for-purpose' development activity prioritizes several key areas which support GLP tox batches and adhere to initial GMP Production. To effectively bolster IND investigations, featured speaker Qixuan Lu, VP of Global CMC Solutions at BioDuro-Sundia, delves into key topics surrounding process chemistry roles and interventions to harmonize in-depth research with the time, cost, and compliance aspects of IND filing programs.
Join us as we explore critical process chemistry issues that commonly arise during IND filings, such as route selection, impurity profile controls, and essential setup criteria for RSM/API. Unlock the secrets to streamline drug development and pave the way to successful IND submissions.